FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313465538> ?p ?o ?g. }

• W4313465538 abstract "Human leukocyte antigen G (HLA-G) is an immune checkpoint molecule with relevance in several cancers. The aim of this study was to evaluate the potential role of soluble HLA-G (sHLA-G), its genetic polymorphisms and its haplotype structure in the susceptibility and prognosis of primary cervical cancer in a Chinese Han population.We investigated sHLA-G plasma levels and 3' untranslated region (3'UTR) polymorphisms through ELISA and direct DNA sequencing, respectively, in cervical cancer patients (120 cases) and healthy control women (96 cases). The data were analyzed for associations using PowerMarker, Haploview, and GraphPad Prism.In this study, 8 polymorphic sites, 16 haplotypes and 23 diplotypes in the HLA-G 3'UTR were identified in our study population. We observed that each pair of 8 polymorphic sites exhibited linkage disequilibrium. The heterozygote CT genotype at position +3422 (rs17875408) was more common in cervical cancer patients than in healthy women (OR=5.285, P<0.05). Haplotypes UTR-1, UTR-3, and UTR-7 accounted for more than 85% of both groups, but no significant difference was found. The frequency of the UTR-1/UTR-3 diplotype in patients was significantly higher than that in controls (P<0.05). In addition, we further observed that HLA-G 3'UTR polymorphisms may influence the sHLA-G plasma level in patients' peripheral blood, especially 14 bp Ins/Del (rs371194629) and +3142 C/G (rs1063320). A receiver operating characteristic (ROC) curve analysis showed that the sHLA-G level had good diagnostic performance in differentiating patients with cervical cancer from healthy women (AUC>0.7). Among patients, mean sHLA-G levels increased with increasing FIGO stages but were not related to the overall survival time.The results of the present study enhance our understanding of how HLA-G 3'UTR polymorphisms can influence the peripheral sHLA-G plasma level and play a key role in cervical carcinogenesis. This study further confirmed that sHLA-G may represent a novel plasma biomarker for the prognosis and potential therapeutic target of cervical cancer." @default.
• W4313465538 created "2023-01-06" @default.
• W4313465538 creator A5012681561 @default.
• W4313465538 creator A5036073738 @default.
• W4313465538 creator A5049298241 @default.
• W4313465538 creator A5055366526 @default.
• W4313465538 creator A5089944154 @default.
• W4313465538 date "2022-12-21" @default.
• W4313465538 modified "2023-10-18" @default.
• W4313465538 title "HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosis" @default.
• W4313465538 cites W1897429505 @default.
• W4313465538 cites W1966273058 @default.
• W4313465538 cites W1967035409 @default.
• W4313465538 cites W1997994653 @default.
• W4313465538 cites W2002982888 @default.
• W4313465538 cites W2008761663 @default.
• W4313465538 cites W2015309791 @default.
• W4313465538 cites W2026053348 @default.
• W4313465538 cites W2031955281 @default.
• W4313465538 cites W2069032846 @default.
• W4313465538 cites W2080150779 @default.
• W4313465538 cites W2089785223 @default.
• W4313465538 cites W2096881368 @default.
• W4313465538 cites W2117497316 @default.
• W4313465538 cites W2128751535 @default.
• W4313465538 cites W2396450716 @default.
• W4313465538 cites W2567757090 @default.
• W4313465538 cites W2605631990 @default.
• W4313465538 cites W2799825000 @default.
• W4313465538 cites W2907994628 @default.
• W4313465538 cites W2946528183 @default.
• W4313465538 cites W3037765409 @default.
• W4313465538 cites W3097683670 @default.
• W4313465538 cites W3177797707 @default.
• W4313465538 cites W3198085001 @default.
• W4313465538 cites W4206037631 @default.
• W4313465538 cites W4210313848 @default.
• W4313465538 cites W4281254006 @default.
• W4313465538 cites W4281707778 @default.
• W4313465538 cites W4281715961 @default.
• W4313465538 cites W4294266907 @default.
• W4313465538 cites W608522650 @default.
• W4313465538 doi "https://doi.org/10.3389/fimmu.2022.1076040" @default.
• W4313465538 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36618382" @default.
• W4313465538 hasPublicationYear "2022" @default.
• W4313465538 type Work @default.
• W4313465538 citedByCount "0" @default.
• W4313465538 crossrefType "journal-article" @default.
• W4313465538 hasAuthorship W4313465538A5012681561 @default.
• W4313465538 hasAuthorship W4313465538A5036073738 @default.
• W4313465538 hasAuthorship W4313465538A5049298241 @default.
• W4313465538 hasAuthorship W4313465538A5055366526 @default.
• W4313465538 hasAuthorship W4313465538A5089944154 @default.
• W4313465538 hasBestOaLocation W43134655381 @default.
• W4313465538 hasConcept C104317684 @default.
• W4313465538 hasConcept C105580179 @default.
• W4313465538 hasConcept C121608353 @default.
• W4313465538 hasConcept C126322002 @default.
• W4313465538 hasConcept C135763542 @default.
• W4313465538 hasConcept C143998085 @default.
• W4313465538 hasConcept C147483822 @default.
• W4313465538 hasConcept C153209595 @default.
• W4313465538 hasConcept C180754005 @default.
• W4313465538 hasConcept C188280979 @default.
• W4313465538 hasConcept C197754878 @default.
• W4313465538 hasConcept C203014093 @default.
• W4313465538 hasConcept C2778220009 @default.
• W4313465538 hasConcept C2780027760 @default.
• W4313465538 hasConcept C2908647359 @default.
• W4313465538 hasConcept C35605836 @default.
• W4313465538 hasConcept C54355233 @default.
• W4313465538 hasConcept C71924100 @default.
• W4313465538 hasConcept C86803240 @default.
• W4313465538 hasConcept C89604277 @default.
• W4313465538 hasConcept C90924648 @default.
• W4313465538 hasConcept C99454951 @default.
• W4313465538 hasConceptScore W4313465538C104317684 @default.
• W4313465538 hasConceptScore W4313465538C105580179 @default.
• W4313465538 hasConceptScore W4313465538C121608353 @default.
• W4313465538 hasConceptScore W4313465538C126322002 @default.
• W4313465538 hasConceptScore W4313465538C135763542 @default.
• W4313465538 hasConceptScore W4313465538C143998085 @default.
• W4313465538 hasConceptScore W4313465538C147483822 @default.
• W4313465538 hasConceptScore W4313465538C153209595 @default.
• W4313465538 hasConceptScore W4313465538C180754005 @default.
• W4313465538 hasConceptScore W4313465538C188280979 @default.
• W4313465538 hasConceptScore W4313465538C197754878 @default.
• W4313465538 hasConceptScore W4313465538C203014093 @default.
• W4313465538 hasConceptScore W4313465538C2778220009 @default.
• W4313465538 hasConceptScore W4313465538C2780027760 @default.
• W4313465538 hasConceptScore W4313465538C2908647359 @default.
• W4313465538 hasConceptScore W4313465538C35605836 @default.
• W4313465538 hasConceptScore W4313465538C54355233 @default.
• W4313465538 hasConceptScore W4313465538C71924100 @default.
• W4313465538 hasConceptScore W4313465538C86803240 @default.
• W4313465538 hasConceptScore W4313465538C89604277 @default.
• W4313465538 hasConceptScore W4313465538C90924648 @default.
• W4313465538 hasConceptScore W4313465538C99454951 @default.
• W4313465538 hasFunder F4320321001 @default.
• W4313465538 hasFunder F4320338464 @default.

• next